Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)

@article{Plyi1993EstablishmentCA,
  title={Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)},
  author={Istv{\'a}n P{\'a}lyi and Ilona P{\'e}ter and D{\'o}ra Daubner and Borb{\'a}la Vincze and Istv{\'a}n L{\~o}rincz},
  journal={Virchows Archiv B},
  year={1993},
  volume={63},
  pages={263-269}
}
SummaryA thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin-and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China

  • Therapeutics and clinical risk management
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines?

  • Thyroid : official journal of the American Thyroid Association
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND